Research assistant professor is the lead author of new research titled ‘The Impact of Drug Court Participation on Mortality: 15-Year Outcomes from a Randomized Controlled Trial’
Research assistant professor Brook Kearley, PhD, is the lead author of new research titled "The Impact of Drug Court Participation on Mortality: 15-year Outcomes from a Randomized Controlled Trial" that was published by the Journal of Substance Abuse Treatment. SSW co-authors include senior research analyst John Cosgrove and assistant professor Alexandra Wimberly.
Highlights
- Participants were randomly assigned to BCDTC or traditional adjudication.
- Over 20 percent of the sample died, largely due to substance use-related causes.
- 15-year mortality rates did not differ between BCDTC and traditional adjudication.
- During the intervention, most participants did not receive MAT.
- Drug courts should implement best practices, including MAT and naloxone training.